Ken d’Entremont is the founder, president, and CEO of Medexus Inc. Previously, he was the general manager and vice president of business development at Sanofi, where he led the in-licensing initiatives for Sanofi Canada. Mr. d’Entremont holds a Bachelor of Science in Chemistry from McMaster University.

• 

  Chief Executive Officer (CEO) in Medexus Pharmaceuticals

  A Leading Innovative Specialty Pharmaceutical Company

• 

  Director in Medexus Pharmaceuticals

  A Leading Innovative Specialty Pharmaceutical Company